Colgate-Palmolive CompanyCLNYSE
Loading

Analyst Sentiment

Analysts lean bullish — 55% recommend buying.

Consensus Rating
Buy
22 analysts·High coverage
55%
Rating Distribution
Strong Buy
00%
Buy
1255%
Hold
1045%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Beat rate:100%(12/12 quarters)
Avg surprise:+3.9%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 20, 2026Goldman Sachs
Colgate-Palmolive price target raised to $100 from $94 at Goldman Sachs
Target:$100.00
+5.2%from $95.09
Feb 13, 2026Redburn Partners
Colgate-Palmolive target raised to $93 from $84 at Rothschild & Co Redburn
Target:$93.00
-3.3%from $96.17
Feb 3, 2026Barclays
Colgate-Palmolive price target raised to $88 from $83 at Barclays
Target:$88.00
-4.2%from $91.89
Feb 2, 2026Morgan Stanley
Colgate-Palmolive price target raised to $100 from $87 at Morgan Stanley
Target:$100.00
+10.8%from $90.29
Feb 1, 2026Wells Fargo
Colgate-Palmolive price target raised to $94 from $86 at Wells Fargo
Target:$94.00
+4.1%from $90.29
Jan 31, 2026Goldman Sachs
Colgate-Palmolive price target raised to $94 from $91 at Goldman Sachs
Target:$94.00
+4.1%from $90.29
Jan 30, 2026Piper Sandler
Colgate-Palmolive price target raised to $96 from $88 at Piper Sandler
Target:$96.00
+7.3%from $89.45
Jan 16, 2026Barclays
Colgate-Palmolive price target raised to $83 from $80 at Barclays
Target:$83.00
-1.6%from $84.31
Jan 14, 2026UBS
Colgate-Palmolive price target raised to $93 from $90 at UBS
Target:$93.00
+11.7%from $83.27
Jan 13, 2026Wells Fargo
Colgate-Palmolive upgraded to Equal Weight from Underweight at Wells Fargo
Target:$86.00
+5.0%from $81.93
Jan 6, 2026Piper Sandler
Piper upgrades Colgate-Palmolive on potential 2026 growth acceleration
Target:$88.00
+14.0%from $77.20
Dec 16, 2025Jefferies
Colgate-Palmolive price target lowered to $85 from $86 at Jefferies
Target:$85.00
+7.7%from $78.95
Dec 9, 2025RBC Capital
Colgate-Palmolive upgraded to Outperform from Sector Perform at RBC Capital
Target:$88.00
+15.6%from $76.11
Nov 3, 2025Evercore ISI
Colgate-Palmolive price target lowered to $94 from $100 at Evercore ISI
Target:$94.00
+24.3%from $75.62
Nov 3, 2025Morgan Stanley
Colgate-Palmolive price target lowered to $87 from $96 at Morgan Stanley
Target:$87.00
+13.6%from $76.57
Oct 10, 2025Deutsche Bank
Colgate-Palmolive price target lowered to $86 from $94 at Deutsche Bank
Target:$86.00
+10.5%from $77.81
Oct 8, 2025UBS
Colgate-Palmolive price target lowered to $92 from $99 at UBS
Target:$92.00
+17.0%from $78.64
Oct 3, 2025Piper Sandler
Colgate-Palmolive assumed with a Neutral at Piper Sandler
Target:$84.00
+7.3%from $78.31
Oct 1, 2025Barclays
Colgate-Palmolive price target lowered to $82 from $87 at Barclays
Target:$82.00
+2.6%from $79.94
Aug 4, 2025Morgan Stanley
Colgate-Palmolive price target lowered to $96 from $104 at Morgan Stanley
Target:$96.00
+15.2%from $83.36
Mar 27, 2025Barclays
Colgate-Palmolive price target raised to $89 from $83 at Barclays
Target:$89.00
-4.5%from $93.19
Sep 23, 2024Piper Sandler
Piper Sandler Starts Colgate-Palmolive Company (CL) at Overweight
Target:$121.00
+17.1%from $103.31
Sep 16, 2024Wells Fargo
Wells Fargo Downgrades Colgate-Palmolive Company (CL) to Underweight, 'Epic Run, Normalization Ahead'
Target:$100.00
-5.4%from $105.73
Jul 22, 2024Stifel Nicolaus
Colgate-Palmolive Company (CL) PT Raised to $105 at Stifel
Target:$105.00
+7.1%from $98.08
May 28, 2024Morgan Stanley
Colgate-Palmolive Company (CL) PT Raised to $103 at Morgan Stanley
Target:$103.00
+10.4%from $93.30